Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents

被引:10
|
作者
Itriyeva, Khalida [1 ,2 ]
机构
[1] Northwell Hlth, Div Adolescent Med, Cohen Childrens Med Ctr, New Hyde Pk, NY USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA
关键词
ADULT WOMENS KNOWLEDGE; BONE-MINERAL DENSITY; MEDROXYPROGESTERONE ACETATE; INTRAUTERINE-DEVICE; YOUNG-WOMEN; WEIGHT-GAIN; INNER-CITY; CONTINUATION; IMPLANTS; FAILURE;
D O I
10.1016/j.cppeds.2018.11.002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The intrauterine devices (IUDs) and the subdermal implant, collectively known as long-acting reversible contraceptives (LARC), along with the Depo-Provera shot, represent highly efficacious methods of birth control for all reproductive-age women, including adolescents. They are also safe, private, and convenient, and can be used for their noncontraceptive benefits. Additionally, LARC and Depo-Provera represent methods of contraception that do not contain estrogen and may be safely used in young women who have contraindications to estrogen-containing medications. The LARC methods have traditionally been underused by adolescents due to lack of knowledge and misperceptions about safety and effects on future fertility. How-ever, studies have found that when barriers to the use of LARC are removed, adolescents have increasingly chosen the IUD and implant for birth control and most continue to use these methods with satisfaction. This chapter will provide an over-view of IUDs, the subdermal implant and Depo-Provera, address barriers to care for adolescents, efficacy, continuation rates, common side effects and reasons for discontinuation, contraindications, and noncontraceptive benefits.
引用
收藏
页码:321 / 332
页数:12
相关论文
共 50 条
  • [41] Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review
    Marmett, Bruna
    Guaranha, Daniela Dal Forno Kinalski
    de Carvalho, Amanda Ferreira
    Reis, Julia Mathias
    de Souza, Carmem Lisiane Escouto
    Dalcin, Tiago Chagas
    Amantea, Sergio Luis
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2024, 37 (01) : 11 - 17
  • [42] Providing Long-acting Reversible Contraception to Adolescents: A Review
    Bahar, Yasmin Z.
    Gold, Melanie A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2020, 63 (03): : 561 - 573
  • [43] Benefits from Long-acting reversible contraceptives (LARC) use in adolescents and the role of paediatricians
    Zampetaki, Charisti
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 176 - 177
  • [44] Long-Acting Reversible Contraception: Specific Issues for Adolescents
    Menon, Seema
    PEDIATRICS, 2020, 146 (02)
  • [45] Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC)
    Parks, Caitlin
    Peipert, Jeffrey F.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (06) : 681 - 688
  • [46] Use of Depo-Provera® (DMPA) in parenting and non-parenting adolescents
    Bruner, AB
    Yialamas, M
    Wilson, M
    JOURNAL OF ADOLESCENT HEALTH, 1998, 22 (02) : 172 - 172
  • [47] Factors associated with weight gain of adolescents on Depo-Provera
    Mangan, SA
    Larsen, PG
    Harr, DS
    PEDIATRIC RESEARCH, 2000, 47 (04) : 8A - 8A
  • [48] Postpartum long-acting reversible contraception (LARC) continuation - A Quasi experimental study
    Wasim, T.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 200 - 201
  • [49] Long-acting Reversible Contraception (LARC) Provision by Family Physicians: Low But on the Rise
    Chelvakumar, Meenadchi
    Jabbarpour, Yalda
    Coffman, Megan
    Jetty, Anuradha
    Shaw, Jonathan Glazer
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (01) : 10 - 12
  • [50] Use of long-acting reversible contraception among adolescents and young women in Kenya
    Kungu, Wambui
    Khasakhala, Anne
    Agwanda, Alfred
    PLOS ONE, 2020, 15 (11):